Back

Medscape, LLC

  • alpha 1-Antitrypsin Deficiency

The Z Factor: Implementing a New Alpha-1 Antitrypsin Deficiency Liver Disease Consensus

The goal of this activity is for learners to be better able to recognize alpha-1 antitrypsin deficiency (AATD)-associated liver disease in clinical practice, navigating the latest diagnostic algorithms, coordinating multidisciplinary care, and understanding emerging options in order to optimize long-term outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.75 credits

MOC types

ABIM — Medical KnowledgeUp to 0.75 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.75 credits
  • MOC · Up to 0.75 points
  • Commercial Support
  • Released
    Jul 8, 2026
  • Last day to claim credit
    Jul 9, 2027 9 months left